Internal Pipeline (undisclosed)

About Lynx Biosciences

Lynx Biosciences is a San Diego-based biotech company pioneering a data-first, multi-omic platform for drug discovery in immuno-oncology. The company combines patient-derived ex vivo models, high-content imaging, and deep learning to generate systems-level biological insights, which it applies through strategic partnerships with biopharma companies and an internal therapeutic pipeline. Founded in 2019 and incubated at J&J JLABS, LynxBio is led by an experienced team and has appointed a Chief Business Officer with a strong track record in oncology partnering to drive its commercial strategy and growth.

About Secarna Pharmaceuticals

Secarna Pharmaceuticals is a private, pre-clinical stage biotech based in Martinsried, Germany, founded in 2005. The company's core asset is its AI-driven OligoCreator® platform, which integrates delivery technologies to rapidly identify and characterize novel oligonucleotide drug candidates. Secarna operates through a hybrid business model, advancing its own pipeline in oncology and immunology while actively partnering its platform with other biopharmaceutical companies. Recent strategic collaborations with entities like Curie.Bio and Protalix BioTherapeutics highlight its role as a technology enabler in the oligonucleotide space.

Therapeutic Areas

Other Oncology (Immuno-oncology focus) Drugs